Drug Shortage Report for ESOMEPRAZOLE
| Report ID | 121840 |
| Drug Identification Number | 02394847 |
| Brand name | ESOMEPRAZOLE |
| Common or Proper name | ESOMEPRAZOLE |
| Company Name | PRO DOC LIMITEE |
| Market Status | MARKETED |
| Active Ingredient(s) | ESOMEPRAZOLE |
| Strength(s) | 40MG |
| Dosage form(s) | TABLET (DELAYED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 30,500 |
| ATC code | A02BC |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2020-08-10 |
| Estimated end date | 2021-08-30 |
| Actual end date | 2021-08-27 |
| Shortage status | Resolved |
| Updated date | 2021-08-28 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
| Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.